ADVB$2.22+6.99%
Advanced Biomed Inc.
Sector: Services-Medical LaboratoriesIndustry: Medical - Diagnostics & ResearchCountry: USExchange: Nasdaq
Mkt Cap:$3.67M
Float & O/S:
Inst Own:
DilutionScan read 12 of Advanced Biomed Inc.'s SEC filings and found 1 warrant series, 1 equity line, 2 S-1 registrations and 3 completed offerings on file for ADVB. The latest dilution event on file is an offering on Apr 30, 2026. Analysis updated Oct 19, 2026.
Signal8 Summary
ADVB
Going-concern warning and business pivot
Snapshot
Advanced Biomed is a pre-revenue micro-cap in the middle of a drastic identity change. FY 2025 financials show $0 in revenue and a $102K net loss, but the company has signaled a shift away from its core bio-med R&D toward AI financial audit solutions.
What's Happening Right Now
- : The company agreed to sell its Taiwan subsidiary, which contains its core biomedical R&D operations, for $490,000.
- : The company disclosed a going-concern warning despite reporting a one-time profit, citing cash outflows and reliance on external financing.
